Publications by authors named "Eleanor Howgate"

Claim this Profile
C
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug-Drug Interactions.
Cornelius Cilliers, Eleanor Howgate, Hannah M Jones, Lisa Rahbaek, Jonathan Q Tran

Clin Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and application of a PBPK modeling strategy to support antimalarial drug development.
Nada Abla, Eleanor Howgate, Karen Rowland-Yeo, Maurice Dickins, Mackenzie C Bergagnini-Kolev

CPT Pharmacometrics Syst Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Developmental Midazolam and 1-Hydroxymidazolam Data with Pediatric Physiologically Based Modeling to Assess Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyl Transferase 2B4 Ontogeny In Vivo.
Trevor N Johnson, Eleanor M Howgate, Saskia N de Wildt, Mark A Turner, Karen Rowland Yeo

Drug Metab Dispos· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Drug-Drug Interaction Liability for Buprenorphine Extended-Release Monthly Injection Administered by Subcutaneous Route.
Jahnavi Kharidia, Eleanor M Howgate, Celine M Laffont, Yongzhen Liu, Malcolm A Young

Clin Pharmacol Drug Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: data from 10 phase I trials.
Parul Patel, Eleanor Howgate, Paul Martin, David J Carlile, Leon Aarons

Br J Clin Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.
Helen E Cubitt, Karen R Yeo, Eleanor M Howgate, Amin Rostami-Hodjegan, Zoe E Barter

Xenobiotica· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the clearance of CYP2C9 substrates.
Karen Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, Amin Rostami-Hodjegan

Drug Metab Dispos· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis